EFFERALGAN PEDIATRIQUE 30 mg/ml, oral solution bottle, 150 ml
Brand page: Doliprane, Dafalgan, Efferalgan (paracetamol) — all forms and strengths in France
Active ingredients: Paracetamol
Commercialized according to BDPM
Oral solutionbottle, 150 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- EFFERALGAN PEDIATRIQUE 30 mg/ml, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène téréphtalate avec fermeture de sécurité enfant de 150 ml avec cuillère doseuse en polystyrène
- Marketing authorisation holder
- UPSA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Jun 2024
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63390065CIP73778438CIP133400937784382Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PARACÉTAMOLsolution | 3,000 g · 100 ml de solution buvable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.